Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular Subtypes of Cholangiocarcinoma and their Translational Implications.

Gastroenterology·2026
Same author

Pre-Treatment Serum Albumin Concentration Predicts Clinical Benefit of Long-Term Albumin in Patients With Cirrhosis and Ascites.

United European gastroenterology journal·2026
Same author

Cancer neuroscience in cholangiocarcinoma: from perineural invasion to neuroimmune control.

Gut·2026
Same author

Altered global longitudinal strain is a common finding in liver transplant recipients with mild cardiometabolic burden.

Internal and emergency medicine·2026
Same author

Clinical predictors of response to Atezolizumab-bevacizumab in Child-Pugh B patients with hepatocellular carcinoma.

JHEP reports : innovation in hepatology·2026
Same author

Sarcopenia Predicts Mortality and Hepatic Encephalopathy After TIPS in Older Adults With Cirrhosis and Improves Prognostic Scores.

Liver international : official journal of the International Association for the Study of the Liver·2026

Related Experiment Video

Updated: Sep 22, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

930

Metabolic reprogramming in cholangiocarcinoma.

Chiara Raggi1, Maria Letizia Taddei1, Colin Rae2

  • 1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Journal of Hepatology
|May 20, 2022
PubMed
Summary

Cancer cells reprogram metabolism to fuel growth, with cholangiocarcinoma (CCA) exhibiting unique nutrient dependencies. Targeting these metabolic vulnerabilities offers potential new therapies for this aggressive liver cancer.

Keywords:
CD36IDH1/2PGC1αcancer stem cellsfatty acid synthasefatty acidsglutamineglycolysismTORmethionine adenosyltransferasesmitochondriaoxidative metabolism

More Related Videos

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

2.6K
A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
08:40

A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties

Published on: August 7, 2020

6.4K

Related Experiment Videos

Last Updated: Sep 22, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

930
Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

2.6K
A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
08:40

A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties

Published on: August 7, 2020

6.4K

Area of Science:

  • Oncology
  • Cancer Metabolism
  • Biochemistry

Background:

  • Metabolic reprogramming is a key hallmark of cancer, enabling tumor cells to meet high energy demands for proliferation, invasion, and metastasis.
  • Cancer cells develop unique metabolic features to survive in nutrient-poor environments by utilizing alternative nutrients.
  • Cholangiocarcinoma (CCA), a heterogeneous liver cancer, is known for chemotherapy resistance and poor prognosis, with altered metabolic pathways contributing to its progression.

Purpose of the Study:

  • To review the complex metabolic rewiring in cholangiocarcinoma (CCA) development.
  • To discuss the unique nutrient dependencies of CCA cells.
  • To explore potential therapeutic interventions targeting metabolic pathways in CCA.

Main Methods:

  • Literature review of recent studies on cancer cell metabolic plasticity.
  • Analysis of metabolic alterations in CCA, including carbohydrate, amino acid, and lipid metabolism.
  • Discussion of therapeutic strategies targeting nutrient access and metabolic pathways.

Main Results:

  • CCA cells exhibit significant metabolic alterations, including increased aerobic glycolysis and glutamine anaplerosis, to generate biosynthetic intermediates.
  • Metabolic changes involving carbohydrates, amino acids, and lipids are crucial for CCA cell growth and dissemination.
  • CCA cells display unique nutrient addictions driven by metabolic rewiring during tumor development.

Conclusions:

  • Metabolic reprogramming plays a critical role in the development and progression of cholangiocarcinoma.
  • Understanding CCA's specific metabolic vulnerabilities, or nutrient addictions, is key to developing novel therapeutic strategies.
  • Targeting metabolic pathways represents a promising avenue for improving treatment outcomes in cholangiocarcinoma.